Page 2 - Complete Genomics News Today

The BIOSECURE Act (H.R. 7085), which has the potential to severely restrict the ability of U.S. biopharmaceutical companies to collaborate with certain Chinese entities without losing the ability to contract with the U.S. government, has made headlines in recent weeks.

The campaign arm for House Democrats counts one of its top fundraisers as a recent lobbyist for a U.S. government-sanctioned company linked to China's military, records show. Steve Elmendorf was listed by the Democratic Congressional Campaign Committee in a Federal Election Commission filing covering the month of January as a bundler, which refers to influential The campaign arm for House Democrats counts one of its top fundraisers as a recent lobbyist for a U.S.-sanctioned company linked t...

/PRNewswire/ -- Complete Genomics, a California-based life sciences company that provides novel, comprehensive sequencing solutions, today highlighted expanded...

Chinese biotechnology firm WuXi AppTec on Sunday refuted the proposed US Biosecurity Act, which prohibits US federal agencies from having contracts with a number of Chinese biotech firms due to “alleged complicity with the Chinese military,” calling it a false accusation.

A U.S. House Select Committee has written a proposed bill that would limit WuXi Apptec and other Chinese firms as security threats. Mayo Clinic and WuXi AppTec operate a joint venture firm.

A U.S. House Select Committee has written a proposed bill that would limit WuXi Apptec and other Chinese firms as security threats. Mayo Clinic and WuXi AppTec operate a joint venture firm.

A U.S. House Select Committee has written a proposed bill that would limit WuXi Apptec and other Chinese firms as security threats. Mayo Clinic and WuXi AppTec operate a joint venture firm.

A U.S. House Select Committee has written a proposed bill that would limit WuXi Apptec and other Chinese firms as security threats. Mayo Clinic and WuXi AppTec operate a joint venture firm.

A bill in the U.S. Congress that sparked a sell-off in shares of China's WuXi AppTec hit a delay in the Senate this week, a Senate aide and three other sources said on Friday. The bill would prohibit federal agencies from contracting with China's BGI Group, MGI, Complete Genomics, WuXi AppTec, their subsidiaries and other biotechnology companies of concern.

BOSTON — Members of the states congressional delegation are seeking to block several Chinese biotechnology companies from doing business with the federal government amid concerns they are stealing U.S. genetic